News
New tool to improve cancer vaccines receives funding
Immunitrack has been awarded a grant from Eurostars to develop their prediction tool for cancer vaccines.
Norwegian AI-based cancer research gets a boost
The Japanese tech giant NEC Corporation has acquired OncoImmunity AS.
Cross-border courses in the Nordics
Oslo Cancer Cluster Incubator collaborates with partners in Sweden, Norway and Finland to help life science professionals learn from their neighbours.
Meet our new members
We proudly present the new members that have joined our organisation during the second quarter of 2019.
New board members
We are happy to welcome three new members to the board of Oslo Cancer Cluster. Find out what they had to say about entering their new positions.
SINTEF to develop methods in immuno-oncology
SINTEF is looking for new partners to develop methodology for cancer immunotherapy.
DNA profiling on the syllabus
Students got to try DNA profiling at a work placement at Thermo Fisher Scientific, arranged by Oslo Cancer Cluster and Ullern Upper Secondary School.
Nobel Prize winner joins Lytix Biopharma
The Nobel Laureate Dr James Allison and oncologist Dr Padmanee Sharma will become strategic advisors for our member Lytix BioPharma.
Dynamic networking and pitch sessions at ICCS 2019
Oslo Cancer Cluster and its international partners organised the International Cancer Cluster Showcase (ICCS) on 3 June in Philadelphia.
Ultimovacs enters the Oslo Stock Exchange
Oslo Cancer Cluster member Ultimovacs entered the Oslo Stock Exchange on Monday 3 June 2019.
Learning about the human brain
Oslo Cancer Cluster and Ullern Upper Secondary School arranged a work placement for students to learn about neuroscience at the University of Oslo.
A successful first quarter for Nordic Nanovector
Nordic Nanovector raises NOK 225 million in private placements, has Phase II clinical trials in 74 sites in 23 countries and prepares to commercialize the company.
